Shurin, Michael R.
University of Pittsburgh Medical Center,
United States
2025 Rank: 56767
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1081 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56767 | 60374 |
| Total Cites | 609 | 640 |
| H-index | 11 | 12 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 94 | 97 |
| Number of Single+First+Last Authored Papers | 126 | 126 |
| Total Cites to Single+First+Last Authored Papers | 293 | 304 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 531 | 544 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.18 |
| Self-Citation Percentage |
4.84%
|
|
Shurin, Michael R.
University of Pittsburgh Medical Center,
United States
2024 Rank: 79321
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1590 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79321 | 87907 |
| Total Cites | 665 | 685 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 79 | 80 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 316 | 322 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 599 | 609 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
2.92%
|
|
Shurin, Michael R.
University of Pittsburgh,
United States
2023 Rank: 58190
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1292 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58190 | 63411 |
| Total Cites | 686 | 740 |
| H-index | 11 | 12 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 85 | 90 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 316 | 337 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 622 | 647 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
7.30%
|
|
Shurin, Michael R.
University of Pittsburgh Medical Center,
United States
2022 Rank: 78796
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1897 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78796 | 88556 |
| Total Cites | 557 | 602 |
| H-index | 10 | 10 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 59 | 60 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 270 | 284 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 503 | 527 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.14 |
| Self-Citation Percentage |
7.48%
|
|
Shurin, Michael R.
University of Pittsburgh,
United States
2021 Rank: 84361
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1880 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84361 | 91222 |
| Total Cites | 760 | 802 |
| H-index | 14 | 14 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 72 | 76 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 372 | 393 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 679 | 703 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.14 |
| Self-Citation Percentage |
5.24%
|
|
Shurin, Michael R.
University of Pittsburgh Medical Center,
United States
2020 Rank: 96502
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1969 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96502 | 112071 |
| Total Cites | 531 | 567 |
| H-index | 12 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 51 | 52 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 275 | 292 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 470 | 489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
6.35%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.